Personal information

Other IDs

ResearcherID: F-7867-2016
Scopus Author ID: 55520444000

Activities

Collapse all

Employment (1)

Universidad de Castilla-La Mancha - Campus de Toledo: Toledo, Castilla-La Mancha, ES

2015 to present | Profesor Contratado Doctor Interino (Química Orgánica, Inorgánica y Bioquímica)
Employment
Source: Self-asserted source
Raul Calero

Works (10)

New titanocene derivative with improved stability and binding ability to albumin exhibits high anticancer activity

Journal of Inorganic Biochemistry
2021-10 | Journal article
DOI: 10.1016/j.jinorgbio.2021.111562
Part of ISSN: 0162-0134
Source: Self-asserted source
Raul Calero

Music Therapy in the Treatment of Dementia: A Systematic Review and Meta-Analysis

Frontiers in Medicine
2020-05-19 | Journal article
DOI: 10.3389/fmed.2020.00160
Part of ISSN: 2296-858X
Source: Self-asserted source
Raul Calero
grade
Preferred source (of 2)‎

Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma.

Cancer letters
2017-10 | Journal article
DOI: 10.1016/j.canlet.2017.07.021
PMID: 28774796
Source: Self-asserted source
Raul Calero via Europe PubMed Central
grade
Preferred source (of 2)‎

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Nature Communications
2015-11-25 | Journal article
DOI: 10.1038/ncomms9904
Contributors: Malin Wickström; Cecilia Dyberg; Jelena Milosevic; Christer Einvik; Raul Calero; Baldur Sveinbjörnsson; Emma Sandén; Anna Darabi; Peter Siesjö; Marcel Kool et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

Oncogene
2014 | Journal article
DOI: 10.1038/onc.2012.572
EID:

2-s2.0-84891935165
Contributors: Montero, J.C.; Esparís-Ogando, A.; Re-Louhau, M.F.; Seoane, S.; Abad, M.; Calero, R.; Ocaña, A.; Pandiella, A.
Source: Self-asserted source
Raul Calero via Scopus - Elsevier

Effects of epigenetic modificators in combination with small molecule inhibitors of receptor tyrosine kinases on medulloblastoma growth

Biochemical and Biophysical Research Communications
2014 | Journal article
DOI: 10.1016/j.bbrc.2014.07.042
EID:

2-s2.0-84906086373
Contributors: Marino, A.-M.; Frijhoff, J.; Calero, R.; Baryawno, N.; Östman, A.; Johnsen, J.I.
Source: Self-asserted source
Raul Calero via Scopus - Elsevier

Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis

PLoS ONE
2014 | Journal article
DOI: 10.1371/journal.pone.0095628
EID:

2-s2.0-84899725519
Contributors: Calero, R.; Morchon, E.; Johnsen, J.I.; Serrano, R.
Source: Self-asserted source
Raul Calero via Scopus - Elsevier

CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors

BioMed Research International
2013 | Journal article
DOI: 10.1155/2013/385604
Contributors: S. H. Nam-Cha; R. Serrano-Vargas; E. Escario; J. M. Azaña; R. Calero-Oliver; A. G. Martín; E. Poblet
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Novel tyrosine kinase inhibitors in the treatment of cancer

Current Drug Targets
2009 | Journal article
DOI: 10.2174/138945009788488378
EID:

2-s2.0-68349126964
Contributors: Ocana, A.; Serrano, R.; Calero, R.; Pandiella, A.
Source: Self-asserted source
Raul Calero via Scopus - Elsevier

An update on the biology of cancer stem cells in breast cancer

Clinical and Translational Oncology
2008 | Journal article
DOI: 10.1007/s12094-008-0291-9
EID:

2-s2.0-60549089844
Contributors: García Bueno, J.M.; Ocaña, A.; Castro-García, P.; Gil Gas, C.; Sánchez-Sánchez, F.; Poblet, E.; Serrano, R.; Calero, R.; Ramírez-Castillejo, C.
Source: Self-asserted source
Raul Calero via Scopus - Elsevier

Peer review (3 reviews for 1 publication/grant)

Review activity for Journal of inorganic biochemistry. (3)
How many people are using ORCID?